K. Hiyama et al., ALTERATIONS IN TELOMERIC REPEAT LENGTH IN LUNG-CANCER ARE ASSOCIATED WITH LOSS OF HETEROZYGOSITY IN P53 AND RB, Oncogene, 10(5), 1995, pp. 937-944
In the two-stage model of controlling cellular senescence in cultured
human fibro blasts, retinoblastoma (Rb) and p53 proteins may be key fa
ctors regulating the mortality stage 1 mechanism. In addition, the cri
tical loss of telomeric DNA due to the end-replication problem may res
ult in the mortality stage 2 mechanism, Cells which acquire telomerase
activity can overcome the M2 mechanism by stabilizing telomere length
and thus become immortal (telomere hypothesis). At present it is know
n whether cellular immortality is a prerequisite for all human cancers
, To investigate this question and the applicability of the two-stage
model to human cancers, we analysed the relationship between alteratio
ns of telomere length and other genetic changes in lung cancer. Among
60 primary lung cancer tissues, telomere length alterations were obser
ved in 16 tumors (26.7%) including 14 with short and two with elongate
d telomeres. Ten of them revealed allelic loss of both p53 and Rb gene
s, and remaining six showed no abnormalities in both genes. We propose
that inactivation of both p53 and Rb genes may promote cell divisions
causing telomere shortening in lung cancer as in the two-stage model,
while there may be another pathway to overcome both M1 and M2 mechani
sms, especially for adenocarcinoma.